Status:
TERMINATED
Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults
Lead Sponsor:
University of Chicago
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is known successful HIV therapy depends on the patients' ability to take their medicine regularly. This study is designed to find out if an intervention designed to help patients remember to take t...
Detailed Description
--Background-- The management of HIV has changed dramatically since the introduction of highly active antiretroviral therapy (HAART). HAART consists of a drug regimen that targets the virus at variou...
Eligibility Criteria
Inclusion
- patient must have HIV to participate
- patient must be at least 18 years of age or older
- must have been on HAART for six weeks
- must have a working telephone number
Exclusion
- patient is HIV negative
- patient is younger than 18 years of age
- patient has been on HAART for less than 6 weeks
- if patient does not have a working telephone number, he/she cannot participate in the study
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00203853
Start Date
January 1 2005
End Date
March 1 2007
Last Update
September 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637